Clinical Value of Metagenomics Next-Generation Sequencing in Bronchoalveolar Lavage Fluid for Patients with Severe Hospital-Acquired Pneumonia: A Nested Case–Control Study
Tianjun Yang,Qing Mei,Xiaowei Fang,Shoujun Zhu,Yinzhong Wang,Wanli Li,Aijun Pan
DOI: https://doi.org/10.2147/IDR.S356662
2022-04-05
Infection and Drug Resistance
Abstract:Tianjun Yang, 1, 2, &ast Qing Mei, 1, 2, &ast Xiaowei Fang, 1, 2 Shoujun Zhu, 1, 2 Yinzhong Wang, 1, 2 Wanli Li, 1, 2 Aijun Pan 1, 2 1 Department of Intensive Care Unit, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province, 230001, People's Republic of China; 2 Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui Province, 230001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Aijun Pan; Qing Mei, Department of Intensive Care Unit, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, No. 17, Lu Jiang Road, Hefei, Anhui Province, 230001, People's Republic of China, Fax +86-551-62283114, Email ; Background: Metagenomics next-generation sequencing (mNGS) is more efficient in identifying pathogens responsible for pneumonia. However, whether these patients ultimately benefit from this improvement remains unknown. Methods: In this retrospective, nested, case–control study, patients with severe hospital-acquired pneumonia (HAP) who had undergone mNGS of bronchoalveolar lavage fluid while in our intensive care unit from March 2017 to December 2020 (n = 33) were matched in a ratio of 1 to 2 (n = 66) by sex, age, comorbidities, immune status, Acute Physiology and Chronic Health Evaluation II score, severity of pulmonary infection, and use of extracorporeal life support with patients who had undergone conventional microbiological testing only. The primary outcome was 90-day mortality; secondary outcomes being length of intensive care unit stay, duration of mechanical ventilation support, 7-day and 28-day mortality, and efficacy of treatment of pulmonary infection. Results: In the CMT group, 17 patients (25.8%) had negative results, whereas only one (3.0%) had negative results in the mNGS group (P < 0.001). After receipt of microbiology results, antibiotics were altered in 23/33 patients (70.0%) in the mNGS group, but in only 29/66 (43.9%) in the CMT group (P = 0.016). Pulmonary infection-related findings improved in 20/33 patients (60.6%) in the mNGS group in the subsequent 7 days, but in only 25/66 (37.9%) in the CMT group (P = 0.032). However, the 28-day (33.3% vs 31.2%, P = 1.0) and 90-day (48.5% vs 45.5%, P = 0.78) mortality rates did not differ significantly between the two groups. These findings were supported by Cox-regression and Kaplan–Meier survival curve analyses. Conclusion: mNGS is helpful in the treatment of severe HAP but does not improve medium or long-term survival rates, especially in patients with severe comorbidities. Keywords: next generation sequencing, severe hospital-acquired pneumonia, bronchoalveolar lavage fluid, mortality, pathogenic microbes Hospital-acquired pneumonia (HAP) is one of the most frequent causes of hospital-acquired infection. It is typically refractory and significantly affects the prognoses of critically ill patients, especially those with immune dysfunction. The overall mortality rate of HAP is around 10%, increasing to 20% or higher in those admitted to an intensive care unit (ICU). 1–3 Quantitative or semi-quantitative culture of specimens obtained from protected specimen brush or bronchoalveolar lavage is the gold standard for identification of the responsible pathogen. 4–6 However, the rate of identification of pathogenic organisms by this method is only 33–60%. 7,8 Several factors can complicate the diagnostic process, including failure to detect pathogens by conventional laboratory procedures due to the use of antibiotics in the early stages and overlooking anaerobic transport and culture conditions. 9 Furthermore, conventional cultures take 3 days to report in most centers, obviously delaying adjustment of antibiotics. With the development of molecular biology, the improvement in the value of metagenomics next-generation sequencing (mNGS) for pathogen identification has been increasingly recognized, especially regarding the detection of rare, atypical, or slow-growing microorganisms. 10 Initially, mNGS was mainly used for detection of microorganisms in sterile fluids, such as cerebrospinal fluid and blood. 11,12 The value of mNGS for non-sterile body fluids, such as sputum and bronchoalveolar lavage fluid (BALF), is still controversial. In a previous study, we showed that mNGS is more sensitive and specific than conventional microbiological tests (CMTs) -Abstract Truncated-
pharmacology & pharmacy,infectious diseases